Frontiers in Cardiovascular Medicine (Jun 2022)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy

  • Shalin Rawal,
  • Kamal Sharma,
  • Aditya Shah,
  • Shriya Bavishi,
  • Cleris Christian,
  • Parjanya Bhatt,
  • Ashwati Konat

DOI
https://doi.org/10.3389/fcvm.2022.916705
Journal volume & issue
Vol. 9

Abstract

Read online

No abstracts available.

Keywords